These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17436237)

  • 1. Malnutrition and variability in CD4+ cell counts in African populations.
    Eisenhut M
    J Infect Dis; 2007 May; 195(10):1550; author reply 1550-1. PubMed ID: 17436237
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4 counts decline despite nutritional recovery in HIV-infected Zambian children with severe malnutrition.
    Hughes SM; Amadi B; Mwiya M; Nkamba H; Mulundu G; Tomkins A; Goldblatt D
    Pediatrics; 2009 Feb; 123(2):e347-51. PubMed ID: 19124582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is malnutrition not declining in Africa?
    Adelekan DA
    Forum Nutr; 2003; 56():288-9. PubMed ID: 15806905
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
    Nnoruka EN; Chukwuka JC; Anisuiba B
    Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM; Kosinski AS; Bartlett JA
    Antivir Ther; 2007; 12(7):1041-8. PubMed ID: 18018762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simpler tests for immune cells could transform AIDS care in Africa.
    Willyard C
    Nat Med; 2007 Oct; 13(10):1131. PubMed ID: 17917650
    [No Abstract]   [Full Text] [Related]  

  • 10. Is HIV the culprit? Spondyloarthropathy in the Third World.
    Njobvu PD; McGill PE
    J Rheumatol; 1999 Oct; 26(10):2074-5. PubMed ID: 10529117
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement in CD 4 counts in HIV positive patients treated with HAART and antitubercular drugs: an observational study from North India.
    Sharma A; Wanchu A; Bansal V; Singh S; Varma S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):905-7. PubMed ID: 18306602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bamako, not Timbuktu.
    DeGroot AS
    Posit Aware; 2003; 14(2):29. PubMed ID: 12693370
    [No Abstract]   [Full Text] [Related]  

  • 14. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology, physiopathology and therapeutic modalities of HIV infections].
    Belan AG
    Soins; 2009 Apr; (734):32-5. PubMed ID: 19475824
    [No Abstract]   [Full Text] [Related]  

  • 16. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class of antiretroviral therapy and CD4+ T cell count recovery: independence questioned.
    Parienti JJ
    Clin Infect Dis; 2009 Feb; 48(3):370; author reply 370-2. PubMed ID: 19128162
    [No Abstract]   [Full Text] [Related]  

  • 18. Pan-African AIDS treatment movement launched.
    AIDS Treat News; 2002 Sep; (383):7-8. PubMed ID: 12765127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors' reply.
    Crum-Cianflone NF; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK
    AIDS; 2009 Aug; 23(13):1791-2. PubMed ID: 19684484
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.